Thursday, February 11, 2010

HIV AIDS historya

HIV AIDS history

HIV AIDS history goes a long way back in time and it is said that the virus actually originated in the non human primates in the sub Saharn Africa. It is also said to have been transferred to humans only in the late ninetieth century or the early twentieth century. There are two kinds of HIV that are known today. These are called HIV I and HIV II. The former is known to be more virile and can be transmitted more easily. HIV AIDS history also tells us that the HIV that was transferred to humans was actually a SIV also called the Simian Immunodeficiency Virus that effected chimpanzees. Specifically speaking this virus was known to have been originated in West Central Africa. While some feel that the origin was in the Cameroon, there are others that hypothesize that the origins lie in the Sanaga River. The hunter theory seeks to explain how the transfer from SIV to HIV actually happened. It is thought that a bushmeat hunter was probably bitten by a chimpanzee while hunting or butchering the animal. Since the exposure happened to blood and bodily fluids there was a transfer of the virus that happened and then slowly spread to other humans as well to now become an epidemic.

The AIDS in Africa history is interesting but the fact is that the condition has now been reported in almost all countries in the world. The spread has not been too rapid but the fact that there is no cure for the disease has resulted in situation where it can only be prevented to some extent and not treated completely.

The history of AIDS also helps us understand that the transfer can still happen today to various other species on earth. But the non curable nature of the condition and the rampant unsafe sex that some societies indulge in does not make things easier for those who would like to prevent the condition from moving further and adding to the already large numbers.

It is also a fact that while the history of HIV AIDS lies in Africa, there are other nations now that are struggling to keep the count of HIV positive people under control. This is specifically challenging since a patient can be HIV positive for some time and yet now show any signs of the disease for many years to come.

This makes the task of those working against the disease a very difficult one and one does not know when to start doing something about the condition. This is why free testing camps are arranged so that those who are perfectly normal also can be tested for the virus to prevent the spread from going as fast as it did during the early years of HIV AIDS history.

Bush advocates $30B for PEPFAR

Bush advocates $30B for PEPFAR


Yesterday, President Bush implored Congress to extend PEPFAR, the President’s Emergency Plan for AIDS Relief, for an additional 5 years and allocate an additional $30 billion to the program. Initially proposed in the President’s 2003 State of the Union address, PEPFAR targets HIV/AIDS treatment in 15 countries with high HIV/AIDS burdens.

As President Bush noted, the $15 billion allocated to PEPFAR thus far has resulted in antiretroviral drugs for 1.1 million people in these resource limited countries and the increased funding could result in treatment for as many as 2.5 million people. This drug therapy, obviously, will extend and improve the lives of these lucky individuals. Arguably, then, PEPFAR is changing the HIV/AIDS landscape.

The plan cannot, however, be considered an unqualified success. Approximately 30 million people in sub-Saharan Africa alone are HIV positive. Providing treatment to 2.5 million of them is not enough. Until all people, in all countries, have access to the life-saving antiretroviral drugs, we can not be satisfied with any existing plan.

More importantly, we need to examine the restrictions associated with PEPFAR funds. One third of allocated funds must be spent on abstinence programs, despite the clear evidence that condoms are the most effective means of preventing the sexual spread of HIV. No funds can be spent on clean needle exchange programs, despite the clear evidence that needle exchange programs prevent the transmission of HIV and do not lead to increased injection drug use. The $15 billion currently allocated to PEPFAR has made a difference. And the additional $30 billion proposed by President Bush will make an even greater impact on the pandemic. President Bush should be commended for this initiative and his leadership. But President Bush also should be admonished for ignoring the scientific evidence. When it comes to the AIDS pandemic, decisions need to be based on evidence, not one person’s faith-based morality.

Wednesday, February 10, 2010

WHAT ACTIVITIES ARE MOST RISKY?

WHAT ACTIVITIES ARE MOST RISKY?

The highest risk of becoming infected with HIV is from sharing needles to inject drugs with someone who is infected with HIV. When you share needles, there is a very high probability that someone else’s blood will be injected into your bloodstream. Hepatitis virus can also be transmitted by sharing needles.

The next greatest risk for HIV infection is from unprotected sexual intercourse (without a condom). Receptive anal intercourse carries the highest risk. The lining of the rectum is very thin. It is damaged very easily during sexual activity. This makes it easier for HIV to enter the body. The "top" or active partner in anal intercourse seems to run a much lower risk. However, the risk still seems higher than for the active partner in insertive vaginal intercourse.

Receptive vaginal intercourse has the next highest risk. The lining of the vagina is stronger than in the rectum, but is vulnerable to infection. Also, it can be damaged by sexual activity. All it takes is a tiny scrape that can be too small to see. The risk of infection is increased if there is any inflammation or infection in the vagina.

The risk is higher for the receptive partner. However, there is some risk for the active partner in anal or vaginal sex. It’s possible for HIV to enter the penis through any open sores, through the moist lining of the opening of the penis, or through the cells in the mucous membrane in the foreskin or the head of the penis.